Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol. 1998;55(11):1449–1455. doi: 10.1001/archneur.55.11.1449
Clemens TL. Vitamin B12 deficiency and bone health. N Eng J Med. 2014;371:963–964. doi: 10.1056/NEJMcibr1407247
Council for Responsible Nutrition. Dietary supplement use reaches all time high. www.crnusa.org/newsroom/dietary-supplement-use-reaches-all-time-high#
Dash P, Hergenroeder G, Jeter C, Choi H, Kobori N, Moore A. Traumatic brain injury alters methionine metabolism: implications for pathophysiology. Front Syst Neurosci. 2016.10:36. doi: 10.3389/fnsys.2016.00036
Ebly EM, Schaefer JP, Campbell NR, Hogan DB. Folate status, vascular disease and cognition in elderly Canadians. Age Ageing. 1998;27(4):485–491. doi: 10.1093/ageing/27.4.485
Ganji V, Kafai MR. Population references for plasma total homocysteine concentrations for U.S. children and adolescents in the post-folic acid fortification era. J Nutr. 2005;135(9):2253–2256. doi: 10.1093/jn/135.9.2253
Geisel T, Martin J, Schulze B, et al. An etiologic profile of anemia in 405 geriatric For Further Reading 241 patients. Anemia. 2014;932486. doi: 10.1155/2014/942486. Epub 2014 Feb 23.
Giles WH, Croft JB, Greenlund KJ, Ford ES, Kittner SJ. Total homocyst(e)ine concentration and the likelihood of nonfatal stroke: results from the Third National Health and Nutrition Examination Survey, 1988–1994. Stroke. 1998;29(12):2473–2477. doi: 10.1161/01.str.29.12.2473
Goss AM, Gower B, Soleymani T, et al. Effects of weight loss during a very low carbohydrate diet on specific adipose tissue depots and insulin sensitivity in older adults with obesity: a randomized clinical trial. Nutri Metab. 2020;17(64). doi: 10.1186/s12986-020-00481-9
Hannibal L, Lysne V, Bjørke-Monsen A-L, et al. Biomarkers and algorithms for the diagnosis of vitamin B12 deficiency. Front Mol Biosci. 2016;3.27. doi: 10.3389/fmolb.2016.00027
Haan MN, Miller JW, Aiello AE, et al. Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging. Am J Clin Nutr. 2007;85(2):511–517. doi: 10.1093/ajcn/85.2.511
Harkin A. Muscling in on depression. N Eng J Med. 2014;371:2333–2334. doi: 10.1056/NEJMcibr1411568
Hicks GE, Shardell M, Miller RR, et al. Associations between vitamin D status and pain in older adults: The Invecchiare in Chianti Study. J Am Geriatr Soc. 2008;56:785–791. doi: 10.1111/j.1532–5415.2008.01644.x
Ho PI, Ortiz D, Rogers E, Shea TB. Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage. J Neurosci Res. 2002;70(5):694–702. doi: 10.1002/jnr.10416
Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006; 81(3):353–373. doi: 10.4065/81.3.353
Holland TM, Agarwal P, Wang Y, et al. Dietary flavonols and risk of Alzheimer dementia. Neurology. 2020;94(16):e1749–e1756; doi: 10.1212/WNL.0000000000008981
Jáuregui-Lobera I. Iron deficiency and cognitive functions. Neuropsychiatr Dis Treat. 2014;10(10):2087–2095. doi: 10.2147/NDT.S72491
Jochemsen HM, Kloppenborg RP, de Groot LC, et al. Homocysteine, progression of ventricular enlargement, and cognitive decline: the Second Manifestations of Arterial Disease-Magnetic Resonance Study. Alzheimers Dement. 2013;9(3):302–309. doi: 10.1016/j.jalz.2011.11.008. Epub 2012 Aug 3. 242 For Further Reading
Kang JH, Cook N, Manson J, Buring JE, Albert CM, Grodstein F. A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease.
Am J Clin Nutr. 2008;88(6):1602–1610. doi: 10.3945/ajcn.2008.26404
Köhnke C, Herrmann M, Berger K. Associations of major depressive disorder and related clinical characteristics with 25-hydroxyvitamin D levels in middle-aged adults. Nutr Neurosci. 2020;9:1–10. doi: 10.1080/1028415X.2020.1843892. Epub ahead of print.
Lipton SA, Kim WK, Choi YB, et al. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci USA. 1997;94(11):5923–5928. doi: 10.1073/pnas.94.11.5923
Llewellyn DJ, Lang IA, Langa KM, et al. Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med. 2010;170(13):1135–1141. doi: 10.1001/archinternmed.2010.173
Malinow MR, Bostom AG, Krauss RM. Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation. 1999 Jan 5–12;99(1):178–182. doi: 10.1161/01.cir.99.1.178
Masoumi A, Goldenson B, Ghirmai S, et al. 1alpha,25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer’s disease patients. J Alzheimers Dis. 2009;17(3):703–717. doi: 10.3233/JAD-2009-1080
Mizwicki MT, Menegaz D, Zhang J, et al. Genomic and nongenomic signaling induced by 1α,25(OH)2-vitamin D3 promotes the recovery of amyloid-β phagocytosis by Alzheimer’s disease macrophages. J Alzheimers Dis. 2012;29(1):51–62. doi: 10.3233/JAD-2012-110560
Mujica-Parodi LR, Amgalan A, Sultan SF, et al. Diet modulates brain network stability, a biomarker for brain aging, in young adults. Proc Natl Acad Sci. 2020;117(11):6170–6177; doi: 10.1073/pnas.1913042117
Okereke OI, Reynolds CF, Mischoulon D, et al. Effect of long-term vitamin D3 supplementation vs placebo on risk of depression or clinically relevant depressive symptoms and on change in mood scores: a randomized clinical trial. J Am Med Assoc. 2020;324(5):471–480. doi: 10.1001/jama.2020.10224
Paillusson S, Stoica R, Gómez-Suaga P, et al. There’s something wrong with my MAM: the ER – mitochondria axis and neurodegenerative diseases. Trends Neurosci. 2016;39(3):146–157. doi: 10.1016/j.tins.2016.01.008 For Further Reading 243
Pilling LC, Jones LC, Masoli JAH, et al. Low vitamin D levels and risk of incident delirium in 351,000 older UK Biobank participants. J Am Geriatr Soc. 2021;69(2):365–372. doi: 10.1111/jgs.16853. Epub 2020 Oct 5.
Prins ND, den Heijer T, Hofman A, et al. Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study. Neurology. 2002;59(9):1375–1380. doi: 10.1212/01.WNL.0000032494.05619.93
Ravaglia G, Forti P, Maioli F, et al. Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr. 2005;82(3):636–643. doi: 10.1093/ajcn/82.3.636
Regland B, McCaddon A. Alzheimer’s amyloidopathy: an alternative aspect. J Alzheimers Dis. 2019;68(2):483–488. doi: 10.3233/JAD-181007
Rodgers GP, Collins FS. Precision nutrition: the answer to “what to eat to stay healthy.” J Am Med Assoc. 2020;324(8):735–736. doi: 10.1001/jama.2020.13601
Salminen A, Kauppinen A, Suuronen T, Kaarniranta K, Ojala J. ER stress in Alzheimer’s disease: a novel neuronal trigger for inflammation and Alzheimer’s pathology. J Neuroinflammation. 2009:41. doi: 10.1186/1742-2094-6-41
Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Eng J Med. 2002;346(7):476–483. doi: 10.1056/NEJMoa011613
Slinin Y, Paudel ML, Taylor BC, et al. 25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men. Neurology. 2010;74(1):33–41. doi: 10.1212/wnl.0b013e3181c7197b
Smith AD, Refsum H, Bottiglieri T, et al. Homocysteine and dementia: an international consensus statement. J Alzheimers Dis. 2018;62(2):561–570. doi: 10.3233/JAD-171042
Smith AD, Smith SM, de Jager CA, et al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS One. 2010. doi: 10.1371/journal.pone.0012244
Spedding S. Vitamins are more funky than Casimir thought. Australas Med J. 2013;6(2):104–106. doi: 10.4066/AMJ.2013.1588
Taheri S, Lin L, Austin D, Young T, Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLOS Medicine, 2004;1,e62. doi: 10.1371/journal.pmed.0010062
Tezapsidis N, Johnston JM, Smith MA, et al. Leptin: a novel therapeutic strategy 244 For Further Reading for Alzheimer’s disease. J Alzheimers Dis. 2009;16(4):731–740. doi: 10.3233/jad-2009-1021
Tucker KL, Qiao N, Scott T, Rosenberg I, Spiro A III. High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. Am J Clin Nutr. 2005;82(3):627–635. doi: 10.1093/ajcn.82.3.627
Wish JB. Assessing iron status: beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol. 2006 Sep;1 Suppl 1:S4–S8. doi: 10.2215/CJN.01490506
Xu W, Tan L, Wang HF, et al. Meta-analysis of modifiable risk factors for Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2015;86(12):1299–1306. doi: 10.1136/jnnp-2015-310548. Epub 2015 Aug 20.
Yassine HN, Braskie MN, Mack WJ, et al. Association of docosahexaenoic acid supplementation with Alzheimer disease stage in apolipoprotein E ε4 carriers: a review. JAMA Neurol. 2017;74(3):339–347. doi: 10.1001/jamaneurol.2016.4899
Zhao C, Tsapanou A, Manly J, Schupf, N, Brickman AM, Gu, Y. Vitamin D intake is associated with dementia risk in the Washington Heights – Inwood Columbia Aging Project (WHICAP). Alzheimers Dement. 2020;16:1393–1401. doi: 10.1002/alz.12096
Alexander CM, Seifert HA, Blouin RT, Conrad PF, Gross JB. Diphenhydramine enhances the interaction of hypercapnic and hypoxic ventilatory drive. Anesthesiology. 1994;80:789–795.
Boeuf-Cazou O, Bongue B, Ansiau D, Marquie J-C, Lapeyre-Mestre M. Impact of long-term benzodiazepine use on cognitive functioning in young adults: the VISAT cohort. Eur J Clin Pharmacol. 2011;67:1045. doi: 10.1007/s00228-011-1047-y